Clinical Trial Update: Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Gefitinib for brain metastases in non-small cell lung cancer; the update notes the trial status as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastasis
• Non-small Cell Lung Cancer

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Non-Small Cell Lung Cancer, Brain Metastasis | Phase 2 | Status: UNKNOWN